JP2014529473A - 医薬製品および医薬製品の露光を分析する方法 - Google Patents

医薬製品および医薬製品の露光を分析する方法 Download PDF

Info

Publication number
JP2014529473A
JP2014529473A JP2014528661A JP2014528661A JP2014529473A JP 2014529473 A JP2014529473 A JP 2014529473A JP 2014528661 A JP2014528661 A JP 2014528661A JP 2014528661 A JP2014528661 A JP 2014528661A JP 2014529473 A JP2014529473 A JP 2014529473A
Authority
JP
Japan
Prior art keywords
change
product
active ingredient
photosensitivity
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014528661A
Other languages
English (en)
Japanese (ja)
Inventor
グオ，ジェレミー
シュネク，デボラ
スペンサー，ポーラ
サン，リー
Original Assignee
アムジエン・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アムジエン・インコーポレーテツド filed Critical アムジエン・インコーポレーテツド
Publication of JP2014529473A publication Critical patent/JP2014529473A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D79/00—Kinds or details of packages, not otherwise provided for
    • B65D79/02—Arrangements or devices for indicating incorrect storage or transport
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D7/00—Indicating measured values
    • G01D7/005—Indication of measured value by colour change

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
JP2014528661A 2011-09-02 2012-08-31 医薬製品および医薬製品の露光を分析する方法 Pending JP2014529473A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161530824P 2011-09-02 2011-09-02
US61/530,824 2011-09-02

Publications (1)

Publication Number Publication Date
JP2014529473A true JP2014529473A (ja) 2014-11-13

Family

ID=46982918

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014528661A Pending JP2014529473A (ja) 2011-09-02 2012-08-31 医薬製品および医薬製品の露光を分析する方法

Country Status (13)

Country Link
US (1) US20140315187A1 (fr)
EP (1) EP2750989A1 (fr)
JP (1) JP2014529473A (fr)
KR (1) KR20140058669A (fr)
CN (1) CN103917458A (fr)
AU (1) AU2012301656A1 (fr)
BR (1) BR112014004591A2 (fr)
CA (1) CA2840637A1 (fr)
CL (1) CL2014000104A1 (fr)
EA (1) EA201490555A1 (fr)
MX (1) MX2014002533A (fr)
WO (1) WO2013033600A1 (fr)
ZA (1) ZA201309704B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020507532A (ja) * 2017-02-14 2020-03-12 マルパズ・テクノロジーズ・リミテッド 感光性物質用容器

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016202785A1 (fr) 2015-06-17 2016-12-22 Novozymes A/S Contenant
CN113454438A (zh) * 2019-02-22 2021-09-28 科慕埃弗西有限公司 用于确定材料的感光特性的方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
EP0117390B1 (fr) * 1983-02-25 1990-09-05 Lifelines Technology, Inc. Procédé de surveillance de l'exposé incrémental à l'environnement des produits, subissant des changements de qualité progressifs suite aux stimulations extérieures
AU588819B2 (en) 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
US5075222A (en) 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
AU643427B2 (en) 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US5395760A (en) 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
DK0417563T3 (da) 1989-09-12 2000-11-06 Hoffmann La Roche TNF-bindende proteiner
US6204363B1 (en) 1989-10-16 2001-03-20 Amgen Inc. Stem cell factor
US5149792A (en) 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs
US5272064A (en) 1989-12-19 1993-12-21 Amgen Inc. DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
AU651596B2 (en) 1990-06-05 1994-07-28 Immunex Corporation Type II interleukin-1 receptors
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
US5962406A (en) 1991-10-25 1999-10-05 Immunex Corporation Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
JPH06174600A (ja) * 1992-09-16 1994-06-24 Caterpillar Inc 状態変化を表示する方法および装置
ES2198414T3 (es) 1992-10-23 2004-02-01 Immunex Corporation Procedimientos para preparar proteinas oligomericas solubles.
US5554512A (en) 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US5981713A (en) 1994-10-13 1999-11-09 Applied Research Systems Ars Holding N.V. Antibodies to intereleukin-1 antagonists
DE69635480T2 (de) 1995-06-29 2006-08-17 Immunex Corp., Thousand Oaks Apoptosis induzierendes cytokin
US6613544B1 (en) 1995-12-22 2003-09-02 Amgen Inc. Osteoprotegerin
US6096728A (en) 1996-02-09 2000-08-01 Amgen Inc. Composition and method for treating inflammatory diseases
US6271349B1 (en) 1996-12-23 2001-08-07 Immunex Corporation Receptor activator of NF-κB
US6235883B1 (en) 1997-05-05 2001-05-22 Abgenix, Inc. Human monoclonal antibodies to epidermal growth factor receptor
US6337072B1 (en) 1998-04-03 2002-01-08 Hyseq, Inc. Interleukin-1 receptor antagonist and recombinant production thereof
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
WO2001036637A1 (fr) 1999-11-17 2001-05-25 Immunex Corporation Activateur du recepteur de nf-kappa b
CA2407956A1 (fr) 2000-05-03 2001-11-08 Amgen Inc. Peptides modifies utilises comme agents therapeutiques

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020507532A (ja) * 2017-02-14 2020-03-12 マルパズ・テクノロジーズ・リミテッド 感光性物質用容器

Also Published As

Publication number Publication date
EP2750989A1 (fr) 2014-07-09
ZA201309704B (en) 2014-08-27
BR112014004591A2 (pt) 2017-03-28
MX2014002533A (es) 2014-08-26
WO2013033600A1 (fr) 2013-03-07
CN103917458A (zh) 2014-07-09
AU2012301656A1 (en) 2014-01-16
CA2840637A1 (fr) 2013-03-07
KR20140058669A (ko) 2014-05-14
US20140315187A1 (en) 2014-10-23
CL2014000104A1 (es) 2014-07-25
EA201490555A1 (ru) 2014-07-30

Similar Documents

Publication Publication Date Title
Razinkov et al. Accelerated formulation development of monoclonal antibodies (mAbs) and mAb-based modalities: review of methods and tools
Visser et al. Physicochemical and functional comparability between the proposed biosimilar rituximab GP2013 and originator rituximab
Kim et al. Aggregation of anti-streptavidin immunoglobulin gamma‐1 involves Fab unfolding and competing growth pathways mediated by pH and salt concentration
Bardin et al. Guidelines for the practical stability studies of anticancer drugs: a European consensus conference
Goetze et al. Assessing monoclonal antibody product quality attribute criticality through clinical studies
Picardo et al. Structure and optimization of checkpoint inhibitors
CN102695956B (zh) 用于检测对治疗性抗IgE抗体特异性的抗体的测定法及其在过敏反应中的用途
ES2349885T3 (es) Análisis de la citotoxicidad celular que depende de anticuerpos.
CN106370861B (zh) 一种c反应蛋白唾液检测试纸条及其制备方法
Xie et al. Demonstrating analytical similarity of trastuzumab biosimilar HLX02 to Herceptin® with a panel of sensitive and orthogonal methods including a novel FcγRIIIa affinity chromatography technology
JP2014529473A (ja) 医薬製品および医薬製品の露光を分析する方法
Hutterer et al. Assessing analytical and functional similarity of proposed Amgen biosimilar ABP 980 to trastuzumab
CN103619877B (zh) 修饰的可变结构域分子及其产生和使用方法b
Kagdi et al. Determination of holdup volume and transient contact compatibility of closed system transfer devices for a reconstituted lyophilized drug product
Schreiber et al. Physicochemical analysis and biological characterization of FKB327 as a biosimilar to adalimumab
JP2023068027A (ja) 免疫チェックポイント阻害剤ｐｄ－１及びｐｄ－ｌ１に対する抗体治療をモニタリングするためのイムノアッセイ及び操作されたタンパク質
Gürel et al. Optimized methods for analytical and functional comparison of biosimilar mAb drugs: A case study for Avastin, Mvasi, and Zirabev
Ambrogelly The different colors of mAbs in solution
Dash et al. Assessment of functional characterization and comparability of biotherapeutics: a review
Gurel et al. Structural and functional analysis of CEX fractions collected from a novel avastin® biosimilar candidate and its innovator: a comparative study
Hambly et al. Detection and quantitation of IgG 1 hinge aspartate isomerization: a rapid degradation in stressed stability studies
US20190079100A1 (en) Methods of glycoprotein analysis
Bondarenko et al. Identification of critical chemical modifications and paratope mapping by size exclusion chromatography of stressed antibody-target complexes
Razinkov et al. High-throughput formulation development of biopharmaceuticals: practical guide to methods and applications
CA2999866C (fr) Composition et methodes pour evaluer la sensibilite et la specificite de reactifs de detection d'anticorps